Testing if the drug letrozole reaches brain tumors in people with a glioma that came back
Official title: Study of Letrozole in Recurrent Gliomas
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study checks whether a drug called letrozole can get into a brain tumor.
Read our full plain-language summary
What the trial team says
The purpose of this study is to determine the ability of letrozole to penetrate the blood brain barrier and concentrate in gliomas.
Key facts
- Registry number
- NCT03122197
- Stage of testing
- Early phase 1
- Conditions studied
- Brain Tumor
Where it is running
This trial lists 1 site.
-
Ohio
- University of Cincinnati (Cincinnati)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.